Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
arGEN-X SE (GB:0QW0)
LSE:0QW0
Holding GB:0QW0?
Track your performance easily
0QW0 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€322.90 - €614.40
Previous Close€601.85
Volume401.00
Average Volume (3M)13.70K
Market Cap
€36.50B
Enterprise Value€34.55B
Total Cash (Recent Filing)$2.05B
Total Debt (Recent Filing)$20.00M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Feb 27, 2025EPS Estimate
€1.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.23
Shares Outstanding55,469,387
10 Day Avg. Volume17,556
30 Day Avg. Volume13,698
Standard Deviation0.11
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)15.07
Price to Sales (P/S)111.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue162.07
Enterprise Value/Gross Profit31.17
Enterprise Value/Ebitda-75.76
Forecast
1Y Price Target
€636.00Price Target Upside5.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
arGEN X News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
12.76% Mutual Funds
― Other Institutional Investors
80.07% Public Companies and
Individual Investors
0QW0 FAQ
What was arGEN-X SE’s price range in the past 12 months?
arGEN-X SE lowest share price was €322.90 and its highest was €614.40 in the past 12 months.
What is arGEN-X SE’s market cap?
Currently, no data Available
When is arGEN-X SE’s upcoming earnings report date?
arGEN-X SE’s upcoming earnings report date is Feb 27, 2025 which is in 62 days.
How were arGEN-X SE’s earnings last quarter?
arGEN-X SE released its earnings results on Oct 31, 2024. The company reported €1.28 earnings per share for the quarter, beating the consensus estimate of €0.127 by €1.153.
Is arGEN-X SE overvalued?
According to Wall Street analysts arGEN-X SE’s price is currently Undervalued.
Does arGEN-X SE pay dividends?
arGEN-X SE does not currently pay dividends.
What is arGEN-X SE’s EPS estimate?
arGEN-X SE’s EPS estimate is €1.13.
How many shares outstanding does arGEN-X SE have?
arGEN-X SE has 60,367,650 shares outstanding.
What happened to arGEN-X SE’s price movement after its last earnings report?
arGEN-X SE reported an EPS of €1.28 in its last earnings report, beating expectations of €0.127. Following the earnings report the stock price went up 3.21%.
Which hedge fund is a major shareholder of arGEN-X SE?
Currently, no hedge funds are holding shares in GB:0QW0
---
Company Description
arGEN-X SE
argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-111, ARGX-109, ARGX-115, ARGX-112, and others. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Switzerland.
---
0QW0 Stock 12 Month Forecast
Average Price Target
€636.00
▲(5.67% Upside)
Technical Analysis
Best Analysts Covering 0QW0
1 Year
1 Year Success Rate
18/22 ratings generated profit
1 Year Average Return
+28.51%
reiterated a buy rating 24 days ago
Copying James Gordon's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +28.51% per trade.
---